ACE2 and COVID-19: Natural immunity and COVID-19 vaccines have modified pathogenesis of COVID-19 and confound analyses of the potential effects of the evolving SARS-CoV-2 virus on ACE2 expression and fibrotic and inflammatory biomarkers.